Wall Street ends mixed as investors eye earnings

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/1/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. ENOV
7. AON
8. AZN
9. BLSM
10. A

Go back to Wall Street ends mixed as investors eye earnings

Intel (INTC) PT Raised to $54 at RBC Capital Into Print; Sees Upside

April 24, 2018 1:29 PM EDT

RBC Capital analyst Amit Daryanani raised his price target on Intel (NASDAQ: INTC) to $54.00 (from $46.00) while maintaining a Sector Perform rating ahead of results on April 26. Daryanani sees Intel well positioned for upside.

"We expect INTC to print upside vs. consensus... More

Merck (MRK) Reports EMA Validation of Type II Variation for KEYTRUDA (pembrolizumab) in Combination with Pemetrexed (ALIMTA) and Platinum Chemotherapy

April 23, 2018 4:35 PM EDT

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that following validation by the European Medicines Agency (EMA), the centralized review process has begun for the companys Type II Variation, which seeks approval for KEYTRUDA, Mercks anti-PD-1 therapy, in combination with pemetrexed (ALIMTA®) and platinum chemotherapy (cisplatin or carboplatin) for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer (NSCLC). The application was accepted for review based on overall survival (OS) and progression-free survival (PFS) data from the Phase 3 KEYNOTE-189 trial, which were recently... More

Stifel Remains Sidelined on Facebook (FB) Ahead of 1Q Release

April 23, 2018 8:27 AM EDT

Stifel reiterated a Hold rating and $168.00 price target on Facebook (NASDAQ: FB) ahead of the company's 1Q earnings report. Analyst Scott Devitt forecasts 1Q revenue to increase +42% y/y to ~$11.43B (versus the Streets estimate of $11.41B), with ad revenue increasing +43%... More